China–Costa Rica FTA – Origin Cumulation Pharmaceutical Products
Quelle: https://www.oecd.org/trade/fta-china-costa-rica.htm
The origin cumulation in the China-Costa Rica FTA allows pharmaceutical products manufactured in Costa Rica, under specified origin criteria, to be considered originating products and thus benefit from tariff preferences.
Related Terms
You might also be interested in these terms
⚖️ ICC Incoterms 2020
Incoterms 2020 Simulator: Who bears costs & risk?
Analyze all 11 Incoterms 2020: cost matrix, risk timeline, insurance gap detector and customs responsibility – free, no login required.